Total Payments
$2,949
2024 Payments
$1,045
Companies
23
Transactions
156
Medicare Patients
2,847
Medicare Billing
$140,058
Payment Breakdown by Category
Food & Beverage$2,949 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,949 | 156 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $364.47 | 25 | $0 (2024) |
| Amgen Inc. | $296.00 | 15 | $0 (2024) |
| Exact Sciences Corporation | $261.68 | 11 | $0 (2024) |
| PFIZER INC. | $236.52 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $213.33 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $208.13 | 10 | $0 (2024) |
| Lilly USA, LLC | $193.09 | 11 | $0 (2024) |
| Celgene Corporation | $179.05 | 9 | $0 (2024) |
| Novo Nordisk Inc | $162.76 | 9 | $0 (2024) |
| Organon LLC | $106.38 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,045 | 58 | ABBVIE INC. ($164.23) |
| 2023 | $989.56 | 52 | PFIZER INC. ($163.41) |
| 2022 | $914.16 | 46 | AstraZeneca Pharmaceuticals LP ($153.13) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: Cardiovascular | ||||||
| 11/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: VACCINES | ||||||
| 10/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Bone Health | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: PAIN | ||||||
| 10/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Endocrinology | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Inflammation | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: VACCINES | ||||||
| 09/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Bone Health | ||||||
| 08/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Obesity | ||||||
| 08/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Oncology | ||||||
| 07/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: VACCINES | ||||||
| 06/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 712 | 933 | $189,167 | $33,709 |
| 2022 | 16 | 962 | 1,222 | $211,667 | $47,079 |
| 2021 | 16 | 956 | 1,207 | $192,917 | $48,047 |
| 2020 | 3 | 217 | 230 | $44,300 | $11,222 |
Total Patients
2,847
Total Services
3,592
Medicare Billing
$140,058
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 264 | $74,976 | $10,870 | 14.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 137 | $26,030 | $5,530 | 21.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 125 | 125 | $42,875 | $5,351 | 12.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 49 | 49 | $3,920 | $3,521 | 89.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 65 | 80 | $30,640 | $3,417 | 11.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 100 | 100 | $4,700 | $1,772 | 37.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 98 | 98 | $2,548 | $1,737 | 68.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 48 | $3,024 | $1,418 | 46.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 21 | $168.00 | $71.61 | 42.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 11 | 11 | $286.00 | $22.66 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 299 | $84,916 | $12,380 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 181 | $34,390 | $7,460 | 21.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 138 | 138 | $47,334 | $6,974 | 14.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $4,800 | $4,480 | 93.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 54 | 55 | $4,410 | $3,763 | 85.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 147 | 147 | $6,909 | $2,641 | 38.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 140 | 140 | $3,640 | $2,469 | 67.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 62 | 63 | $3,969 | $1,778 | 44.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 42 | $4,872 | $1,627 | 33.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 23 | $8,809 | $1,284 | 14.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 11 | $3,630 | $771.73 | 21.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 18 | 19 | $1,066 | $672.62 | 63.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $1,071 | $482.88 | 45.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 17 | $969.00 | $163.25 | 16.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 24 | 29 | $232.00 | $99.73 | 43.0% |
About Dr. David Kobliska, M.D
Dr. David Kobliska, M.D is a Family Medicine healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386651560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kobliska, M.D has received a total of $2,949 in payments from pharmaceutical and medical device companies, with $1,045 received in 2024. These payments were reported across 156 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,949).
As a Medicare-enrolled provider, Kobliska has provided services to 2,847 Medicare beneficiaries, totaling 3,592 services with total Medicare billing of $140,058. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Eugene, OR
- Active Since 08/01/2006
- Last Updated 04/20/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386651560
Products in Payments
- ELIQUIS (Drug) $302.65
- VRAYLAR (Drug) $273.34
- Cologuard Collection Kit (Device) $261.68
- EVENITY (Biological) $246.81
- SHINGRIX (Biological) $196.00
- FARXIGA (Drug) $169.01
- MOUNJARO (Drug) $125.94
- JARDIANCE (Drug) $117.41
- Wegovy (Drug) $93.67
- NEXPLANON (Drug) $87.62
- REXULTI (Drug) $80.64
- Kerendia (Drug) $75.84
- NURTEC ODT (Drug) $66.41
- LEQVIO (Drug) $64.52
- SPRAVATO (Drug) $57.33
- UBRELVY (Drug) $49.77
- Otezla (Drug) $49.19
- SEGLENTIS (Drug) $44.15
- PAXLOVID (Drug) $42.23
- VAXELIS (Biological) $40.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Eugene
Randy Reese, Md, MD
Family Medicine — Payments: $9,360
Family Medicine $9,360
Dr. Patricia Buchanan, M.d, M.D
Family Medicine — Payments: $5,323
Family Medicine $5,323
Hylke Snieder, M.d, M.D
Family Medicine — Payments: $4,297
Family Medicine $4,297
Doherty Gilchrist, Md, MD
Family Medicine — Payments: $1,786
Family Medicine $1,786
Dr. Neema Reddy, Md, MD
Family Medicine — Payments: $1,592
Family Medicine $1,592
Kathleen Cordes, Md, MD
Family Medicine — Payments: $1,452
Family Medicine $1,452